Health
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | NEJM – nejm.org
Correspondence from The New England Journal of Medicine — Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
After emergency use of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was authorized, the observer-blinded, pivotal Coronavirus Efficacy (COVE) trial was amended on December 23, 2020, to include an open-label phase in…
Continue Reading
-
Noosa News20 hours agoChef Sophie Phipps prepares to open restaurant at 30-acre Alsahwa Estate
-
General12 hours ago‘Sovereign citizens’ sentenced to prison term in Western Australia for defiance of court order
-
Noosa News18 hours agoSpectacles of Wonder
-
Noosa News20 hours agoTeens help keep their Riverina family farm running